Hy2Care
The company develops the CartRevive hydrogel implant, a joint-tissue mimicking natural polymer designed for the functional recovery of cartilage defects. This injectable scaffold allows a patient's own cells to deposit new cartilage matrix, aiming to facilitate natural repair and prevent post-traumatic osteoarthritis. The technology primarily targets patients suffering from traumatic cartilage defects resulting from sports accidents or falls.
Healthtech
Medtech
Biotechnology
Funding summary
- Total raised
- €14.2M
- Funding rounds
- 3
Investors in Hy2Care
Investors on record for Hy2Care. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Hy2Care?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors